Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Rebus Hldgs's annualizedGross Profit for the quarter that ended in Jun. 2023 was $0.00 Mil.
Rebus Hldgs's average Total Assets over the quarter that ended in Jun. 2023 was $0.01 Mil. Therefore, Rebus Hldgs's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 0.00%.
Rebus Hldgs Gross-Profit-to-Asset % Historical Data
The historical data trend for Rebus Hldgs's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rebus Hldgs's Gross-Profit-to-Asset %
For the Biotechnology subindustry, Rebus Hldgs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rebus Hldgs's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Rebus Hldgs's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Rebus Hldgs's Gross-Profit-to-Asset % falls into.
Rebus Hldgs Gross-Profit-to-Asset % Calculation
Rebus Hldgs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Jun. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Rebus Hldgs Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Rebus Hldgs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RBSH has been successfully added to your 